top of page
About OsciFlex
OsciFlex LLC was founded in 2017 by John Welsh, PhD and Mark Kahn, MD at the University of Pennsylvania. Dr. Welsh and Dr. Kahn discovered the molecular pathways relating blood flow pattern to endothelial gene expression of thrombosis related proteins, outlined a protocol to analyze venous valve oscillatory flow in human subjects using vascular ultrasound, and created the initial OsciFlex device design.
Venous thromboembolism (VTE) prevention
Post thrombotic syndrome (PTS) treatment
Improved vascular imaging
Core Values
Objectives
Funding Timeline
2017:
-
OsciFlex LLC founded by John Welsh, PhD & Mark Kahn, MD
2019:
-
NSF SBIR PHASE I Grant
-
NIH STTR PHASE 1 Grant
-
Penn Cardiovascular Institute “Dream Team” Award
-
Penn Health Tech Award
-
Basic science publication accept to top journal (JCI 2019)
2021:
-
NIH SBIR PHASE II Grant
Core Values
2022:
-
NSF SBIR PHASE II Grant
Core Values
bottom of page